Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. - Wikidata - wikimedia - TriplyDB

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

http://www.wikidata.org/entity/Q37276912

about

Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines Vaccines for the 21st century Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide.Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3.History of vaccination A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.DNA/MVA Vaccines for HIV/AIDS Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials.A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination.HIV DNA Vaccine: Stepwise Improvements Make a Difference.MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity Tuberculosis vaccine development: Shifting focus amid increasing development challenges.Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis.DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.Clinical potential of electroporation for gene therapy and DNA vaccine delivery.Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines.Present and future DNA vaccines for chronic hepatitis B treatment.Cytomegalovirus Vaccines: Current Status and Future Prospects.Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.Anti-Infectious Human Vaccination in Historical Perspective.Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.Future Approaches to DNA Vaccination Against Hemorrhagic Fever Viruses.Optimization of the immunogenicity of a DNA vaccine encoding a bacterial outer membrane lipoprotein.An effective DNA vaccine platform for Middle East respiratory syndrome coronavirus.DNA Vaccines: Recent Developments and the Future.

P2860

Q26783488-ECB191CA-8111-4D89-9F15-E2F1575D29DD Q27007529-54868A3F-6842-4227-B020-9271B85F4EEE Q28652428-88834053-208B-4370-B37D-F4C61C3F5A5C Q30375785-D4C25D25-0FEC-4065-836D-0CE2E8892ABE Q33868760-E84975FD-0ACF-4AFD-977D-2E5E2D31A0B0 Q33870581-7518BDD1-73BF-4D6B-A849-EF5B717C0497 Q33880398-2A71C9D7-0377-4C49-83B0-CE9B020663F8 Q34046807-828A3AF8-580B-4784-8E97-D9F46ACDC6F7 Q34119899-48409AD6-9EBD-4459-93C3-A98424B5E4EF Q34165062-1F936DD5-66E2-4533-B374-915EAB51AEB7 Q34449537-3D564C2B-C162-4A13-9688-ACEDAFFF8DF2 Q34492802-5B1718D9-0238-47C4-B0E2-7C6F3573623A Q35611969-C3EFFDF8-A37C-4C13-B0C9-C9518DC268C2 Q35739841-203F000A-67F0-46C4-8659-73FD79FFCA50 Q35815995-477821C9-43ED-4D42-B546-1A7121014883 Q35826742-3D746348-3E8A-48BB-A4A9-7169E0BD7BD0 Q36163830-84D0B929-F0F8-4849-A195-C7883A3D2FC3 Q36256304-F8BC1E7D-C1FF-449B-BB04-FFDF9AFBFF73 Q36256319-873F7F60-5530-40BE-8399-A1F9994D8A5D Q36258203-77ED9CBC-E5DC-47E6-8353-D7ED241B4A6A Q36369631-59BB7867-C2D1-406C-832F-8E156AAA03CE Q37375963-AA037B45-70DE-473D-9D15-859F1DEEB062 Q37395174-2E6277B0-A748-4364-B7D9-9E0555132F41 Q37684017-FFAC7B56-0DF1-4190-B8F4-BE5DA8129D71 Q38289734-1A809F25-798C-4332-B0A7-07952BE59FA6 Q38342834-F068B99C-2619-45BC-AD0F-75E3E99C7397 Q38540633-2987F23A-1B7B-4893-9E57-F62E6FC78E5D Q38636510-05EB0894-44BF-49F7-B438-502858083B39 Q38730774-AB9A3B41-8F78-44E3-8110-75CF39A63594 Q38756963-2AAC1421-3D98-4A10-95C2-8DD8446D3813 Q38790065-98EAD56C-9450-4580-87AB-32C184B19949 Q38791353-C3B7F38F-05CC-4F4E-9A0B-063B821BF48D Q40071705-77D38D8F-3A64-49D4-A340-402085C9852B Q40129444-889DC8A8-757C-43A7-9974-03EB703360D7 Q40160424-C9CE25EA-5D90-4AFD-953A-620D7814E3F9 Q41435861-7A4EF062-5FA1-496A-BC17-02CEA1AF35DD Q41922339-52137303-C356-4B11-9D7F-2D3A70995140 Q42216302-2331E56C-C79D-4D5D-B268-CE164D37A40B Q42330835-7C0C451C-2AB9-4A7D-B389-67E07B8BE9DC Q45892465-914C5EF3-12A6-4913-8892-BC1C0A70BE12

P2860

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

http://www.wikidata.org/entity/Q37276912

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Synthetic DNA vaccines: improv ...... o-delivered genetic adjuvants.

@en

Synthetic DNA vaccines: improv ...... o-delivered genetic adjuvants.

@nl

type

label

Synthetic DNA vaccines: improv ...... o-delivered genetic adjuvants.

@en

Synthetic DNA vaccines: improv ...... o-delivered genetic adjuvants.

@nl

prefLabel

Synthetic DNA vaccines: improv ...... o-delivered genetic adjuvants.

@en

Synthetic DNA vaccines: improv ...... o-delivered genetic adjuvants.

@nl

P1433

Q37276912-F0E80EC3-5EBF-4745-98E5-71420B791DFE

P1476

Q37276912-881C1FA6-A873-4E15-9ED1-86ABCB3D9F05

P2093

Q37276912-3AC2C098-A433-407C-81A3-48F0DD6DD5E8

Q37276912-4570898E-B1C5-47D0-B98B-C0DA52D3BDCB

Q37276912-B5ACF6F0-6CD0-4730-B5E0-0AC6D0D2B54C

Q37276912-BB3E2393-2334-4977-B296-EF0CD4577B03

Q37276912-F45CA145-B7F8-4903-988B-E19FB00A979C

P2860

Q37276912-04C425B4-DB8E-41D4-9F37-EE93B9A3CDE7

Q37276912-05F5D662-BC41-4C46-BF04-C9C79A3BAD06

Q37276912-0BC46D05-19C8-4E91-A4A9-E620D5A7C74A

Q37276912-0D9F7331-1D84-4BBF-B4C5-ABDC34C6B449

Q37276912-0F3D9ABA-8B43-4CD8-8128-67A2EACE4CF9

Q37276912-0F6065A1-2376-4072-BE7A-58FC6D44F3EF

Q37276912-0FC3DDD6-CF52-4C5A-A10B-74AECFBB2175

Q37276912-1110FB5D-D0F2-4D8B-8C0D-616CAAC8E41E

Q37276912-12985174-33DF-4062-B732-D8BB29A0C723

Q37276912-1363B037-6C4B-4472-86D0-E8478A9624A6

P304

Q37276912-36CCA136-DA8E-4959-AF64-AE08206590E6

P31

Q37276912-80CDB2D2-442C-4D38-8A2E-CC2FC5D31DD9

P356

Q37276912-7016DFC5-7EF6-48B4-AF4A-3471AEC7D203

P478

Q37276912-B119B8FB-272D-4096-BC03-745BA5B5B2C9

P50

Q37276912-FEED10CB-0DBB-4852-9337-06FD7D4BE147

P577

Q37276912-D7D80097-401C-4BEB-9409-121C4743D29E

P5875

Q37276912-9A9BC5C8-4DEF-4A23-91D3-9C9947E6C147

P698

Q37276912-83CB38C6-795D-4D99-9D61-20C7BE39C197

P921

Q37276912-78D3C135-E87B-4AA5-AD7E-07B5300083F2

P932

Q37276912-15B141A5-3946-4504-9E8A-DC22BB9ADB72

P356

FIMMU.2013.00354

P1433

Frontiers in Immunology

P1476

Synthetic DNA vaccines: improv ...... co-delivered genetic adjuvants

@en

P2093

David B Weiner

http://www.w3.org/2001/XMLSchema#string

Jonathan Goodman

http://www.w3.org/2001/XMLSchema#string

Matias Czerwonko

http://www.w3.org/2001/XMLSchema#string

Sagar B Kudchodkar

http://www.w3.org/2001/XMLSchema#string

Seleeke Flingai

http://www.w3.org/2001/XMLSchema#string

P2860

Class II transactivator: mastering the art of major histocompatibility complex expression

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

Vaccines: the Fourth Century

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

P304

354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2013.00354

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Karuppiah Muthumani

P577

2013-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258350664

http://www.w3.org/2001/XMLSchema#string

P698

24204366

http://www.w3.org/2001/XMLSchema#string

P921

electroporation

P932

3816528

http://www.w3.org/2001/XMLSchema#string